USD 0.27
(0.0%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | -222.81 Thousand USD | 99.9% |
2022 | -920.51 Thousand USD | 78.04% |
2021 | -999.03 Thousand USD | -1206.01% |
2020 | -76.49 Thousand USD | 90.84% |
2019 | -835.34 Thousand USD | 0.0% |
2011 | 876.15 Thousand USD | 296.41% |
2010 | -346.38 Thousand USD | -63.18% |
2009 | -212.26 Thousand USD | 92.27% |
2008 | -13 Million USD | 18.37% |
2007 | -3.36 Million USD | -36722.14% |
2006 | -9134.00 USD | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q1 | -16.16 Thousand USD | -101.07% |
2024 Q2 | -30.1 Thousand USD | -86.27% |
2023 Q4 | 1.55 Million USD | 6481.29% |
2023 Q3 | -24.29 Thousand USD | 98.51% |
2023 Q2 | -1.63 Million USD | -2065.31% |
2023 FY | - USD | 99.9% |
2023 Q1 | -75.53 Thousand USD | -147.79% |
2022 Q2 | -510.52 Thousand USD | -462.27% |
2022 Q1 | -90.79 Thousand USD | 30.96% |
2022 Q3 | -122.38 Thousand USD | 76.03% |
2022 Q4 | 158.04 Thousand USD | 229.14% |
2022 FY | - USD | 78.04% |
2021 Q3 | -407.17 Thousand USD | 34.62% |
2021 Q1 | -92.48 Thousand USD | -443.55% |
2021 FY | - USD | -1206.01% |
2021 Q4 | -131.52 Thousand USD | 67.7% |
2021 Q2 | -622.77 Thousand USD | -573.38% |
2020 Q3 | -16.43 Thousand USD | 36.31% |
2020 Q2 | -25.79 Thousand USD | -19.85% |
2020 Q1 | -21.52 Thousand USD | 0.0% |
2020 FY | - USD | 90.84% |
2020 Q4 | -17.01 Thousand USD | -3.55% |
2019 FY | - USD | 0.0% |
2012 Q2 | -477.11 Thousand USD | -1918.56% |
2012 Q3 | -538.27 Thousand USD | -12.82% |
2012 Q1 | 26.23 Thousand USD | -85.8% |
2011 Q3 | 167.63 Thousand USD | 746.75% |
2011 FY | - USD | 296.41% |
2011 Q4 | 184.75 Thousand USD | 10.22% |
2011 Q2 | -25.91 Thousand USD | -42.58% |
2011 Q1 | -18.17 Thousand USD | -225.36% |
2010 Q1 | -49.6 Thousand USD | 67.17% |
2010 FY | - USD | -63.18% |
2010 Q2 | -13.37 Thousand USD | 73.05% |
2010 Q3 | -19.21 Thousand USD | -43.73% |
2010 Q4 | -5587.00 USD | 70.93% |
2009 Q2 | -209.26 Thousand USD | -119.65% |
2009 Q3 | -132.29 Thousand USD | 36.78% |
2009 Q4 | -151.11 Thousand USD | -14.23% |
2009 FY | - USD | 92.27% |
2009 Q1 | 1.06 Million USD | 324.58% |
2008 Q1 | -1.43 Million USD | -40.81% |
2008 Q4 | -474.22 Thousand USD | 20.14% |
2008 Q3 | -593.81 Thousand USD | -48.98% |
2008 Q2 | -398.59 Thousand USD | 72.21% |
2008 FY | - USD | 18.37% |
2007 FY | - USD | -36722.14% |
2007 Q2 | -1.68 Million USD | -9.49% |
2007 Q3 | -963.26 Thousand USD | 42.75% |
2007 Q4 | -1.01 Million USD | -5.76% |
2007 Q1 | -1.53 Million USD | -4774.64% |
2006 Q3 | -11.9 Thousand USD | 0.0% |
2006 FY | - USD | 0.0% |
2006 Q4 | -31.52 Thousand USD | -164.76% |
Name | EBITDA | EBITDA Difference |
---|---|---|
CVR Medical Corp. | - USD | Infinity% |
BioElectronics Corporation | -274.29 Thousand USD | 18.766% |
IR-Med Inc. | -4.89 Million USD | 95.445% |
Polarean Imaging plc | -11.19 Million USD | 98.01% |
Medical Supply International USA, Inc. | 456.06 Thousand USD | 148.857% |
Avitar, Inc. | -1.66 Million USD | 86.64% |
AVITA Medical, Inc. | -39.56 Million USD | 99.437% |
Manhattan Scientifics, Inc. | -1.16 Million USD | 80.858% |
Össur hf. | 137.38 Million USD | 100.162% |
Zecotek Photonics Inc. | -3.44 Million USD | 93.527% |
QHSLab, Inc. | -91.29 Thousand USD | -144.069% |
Wellstar International, Inc. | -1.35 Million USD | 83.574% |
Össur hf. | 137.38 Million USD | 100.162% |
Bionovate Technologies Corp | - USD | Infinity% |
EKF Diagnostics Holdings plc | 9.77 Million USD | 102.28% |
Escalon Medical Corp. | -58.46 Thousand USD | -281.14% |
Aurora Spine Corporation | -454.37 Thousand USD | 50.962% |
BrainsWay Ltd. | -2.31 Million USD | 90.358% |
Lattice Biologics Ltd. | - USD | Infinity% |
NewCardio, Inc. | -9.37 Million USD | 97.624% |
Hamilton Thorne Ltd. | 5.52 Million USD | 104.035% |
Vivos Inc. | -2.79 Million USD | 92.023% |
MicroPort Scientific Corporation | -347.57 Million USD | 99.936% |
Kelyniam Global, Inc. | -197.69 Thousand USD | -12.71% |
REMSleep Holdings, Inc. | -1.66 Million USD | 86.646% |
CYduct Diagnostics, Inc. | -378.9 Thousand USD | 41.194% |
Nanomix Corporation | -8.13 Million USD | 97.263% |
Theraclion SA | -2.05 Million USD | 89.135% |
Lifeline Biotechnologies, Inc. | - USD | Infinity% |
Wellness Center USA, Inc. | -707.03 Thousand USD | 68.485% |
Positron Corporation | -1.45 Million USD | 84.656% |
Rafina Innovations Inc. | - USD | Infinity% |
Electromedical Technologies, Inc. | -1.72 Million USD | 87.06% |
Lombard Medical, Inc. | -28.06 Million USD | 99.206% |
ALR Technologies Inc. | -6.4 Million USD | 96.519% |
Stratec SE | 39.91 Million USD | 100.558% |
Vycor Medical, Inc. | 100.94 Thousand USD | 320.736% |
Heart Tronics, Inc. | -14.85 Million USD | 98.5% |
Nu-Med Plus, Inc. | -118.25 Thousand USD | -88.415% |
Perimeter Medical Imaging AI, Inc. | -13.27 Million USD | 98.322% |
SANUWAVE Health, Inc. | -9.15 Million USD | 97.565% |
VMS Rehab Systems, Inc. | -68.55 USD | -324944.493% |
Guided Therapeutics, Inc. | -3.12 Million USD | 92.872% |
Ingen Technologies, Inc. | -8639.00 USD | -2479.211% |
Odyssey Group International, Inc. | -2.13 Million USD | 89.579% |
United American Healthcare Corporation | -59 Thousand USD | -277.658% |
ECGI Holdings, Inc. | -2.99 Million USD | 92.549% |
Capital Group Holdings, Inc. | -629.18 Thousand USD | 64.586% |
ADM Tronics Unlimited, Inc. | -514.02 Thousand USD | 56.652% |
Urologix, Inc. | -6.34 Million USD | 96.488% |
Rapid Therapeutic Science Laboratories, Inc. | -1.23 Million USD | 82.022% |
Nexeon MedSystems Inc. | -765.96 Thousand USD | 70.91% |
SS Innovations International, Inc. | -20.37 Million USD | 98.906% |
Smith & Nephew plc | 1 Billion USD | 100.022% |
NIOX Group Plc | 11.07 Million USD | 102.012% |
Fuse Medical, Inc. | 1.83 Million USD | 112.141% |
Broncus Holding Corporation | -25.19 Million USD | 99.116% |
Brain Scientific Inc. | -7.93 Million USD | 97.192% |
Pressure BioSciences, Inc. | -9.39 Million USD | 97.627% |
Health Logic Interactive Inc. | -18.4 Thousand USD | -1110.967% |